Protalix BioTherapeutics
PLX
PLX
28 hedge funds and large institutions have $15.5M invested in Protalix BioTherapeutics in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-5
Holders Change %
-15.15%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
10
Closed
7
Calls
$1K
Puts
$36K
Net Calls
-$35K
Net Calls Change
-$8K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$66K |
| 2 |
VKH
2
Virtu KCG Holdings
New York
|
$7K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$3K |
| 4 |
4
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$3K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ARTA
26
A.R.T. Advisors
New York
| – | -$18K | -2,221 | Closed |
|
|
PCM
27
Penserra Capital Management
Orinda,
California
| – | -$5.38K | -1,680 | Closed |
|
28
HSBC Holdings
London,
United Kingdom
| – | -$13K | -1,500 | Closed |
|
|
MMH
29
Menora Mivtachim Holdings
Ramat Gan,
Israel
| – | -$4K | -515 | Closed |
|